Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc

Overview
Date Founded

2003

Headquarters

Waterloo Exchange,Waterloo Road,Dublin 4

Type of Company

Public

Employees (Worldwide)

1,620

Industries

Pharmaceuticals

Company Description

• About Us • Mission & Values • Management Team • Board of Directors • Board Committees • Commercial Capabilities • Corporate Responsibility • Ethical Sales & Marketing • Drug Safety & Medical Info • Physician Data Restriction Program • California Compliance Declaration • Stories • What’s in a Name? • Business Development • Locations ABOUT US Jazz Pharmaceuticals plc is an international specialty biopharmaceutical company dedicated to helping patients with unmet medical needs. We identify, develop and commercialize innovative products in focused therapeutic areas, with a strong commercial focus and expertise in narcolepsy, oncology, pain and psychiatry. Our marketed product portfolio includes: XYREM® (sodium oxybate), ERWINAZETM (asparaginase Erwinia chrysanthemi), PRIALT® (ziconotide) solution, intrathecal infusion, FAZACLO® (clozapine, USP) LD and HD , and LUVOX CR® (fluvoxamine maleate). The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD, FAZACLO HD and LUVOX CR is intended only for residents of the United States. For more information, including complete prescribing information and boxed warnings, click on the product names above. Please visit www.EUSAPharma.com for more information about our international division, EUSA Pharma, and our products marketed outside the U.S. We plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our unique commercial expertise. As we evaluate additional acquisition and in-licensing opportunities, we work closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals’ unique approach to patient care and patient-focused products may be able to bring a new therapeutic option to the market where none existed previously.

Contact Data
Trying to get in touch with decision makers at Jazz Pharmaceuticals Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Executive Vice President & Chief Financial Officer

Executive Vice President & General Manager, North America

Executive Vice President, Research & Development

Head of EUSA International & Senior Vice President, Jazz Pharmaceuticals

Vice President, Finance & Principal Accounting Officer

Vice President, Investor Relations

Senior Vice President & General Counsel

Senior Director, Investor Relations

Senior Vice President-Technical Operations

Board of Directors

Secretary, Treasurer & Director at Institute for Healthcare Improvement

UDG Healthcare Plc

Lead Corporate Development at Bioaxone Therapeutics, Inc.

Co-Founder at Longitude Capital Management Co. LLC

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Former Managing Director at Reckitt Benckiser Group Plc

Chief Executive Officer at Aptinyx, Inc.

Venture Partner at ARCH Venture Partners

Founder at Azur Pharma Ltd.

Secretary at Mindmaze SA

Paths to Jazz Pharmaceuticals Plc
Potential Connections via
Relationship Science
You
Jazz Pharmaceuticals Plc
Owners & Shareholders
Details Hidden

LSVAM is a quantitative value equity manager that provides active investment management for institutional investors through the application of proprietary investment models. The firm's investment approach is based on the premise that superior long-term results can be achieved by systematically exploiting the judgmental biases and behavioral weaknesses that influence the decisions of many investors. LSVAM uses a strictly quantitative investment model to identify out-of-favor (undervalued) stocks that have the potential for near-term appreciation. They select individual securities using a bottom-up, quantitative approach. All of their investment strategies use the same approach with investments segmented into different market-cap ranges and/or geographic regions.

Details Hidden

DKCM invests client assets using a variety of arbitrage and other event-driven strategies, including risk arbitrage transactions and investments in financially distressed companies. The firm's primary investment strategies include distressed investing, mergers and acquisitions (or risk) arbitrage, long/short equities, and convertible and volatility arbitrage. As distressed investment opportunities are identified, they are subjected to rigorous, fundamental, bottom-up analysis.

Details Hidden

Holocene uses a global, beta neutral, long/short equity strategy, pursuant to which it will invest, long and short, in publicly traded equities and equity-related instruments across all market capitalizations, though they intend to invest predominantly in US-listed mid- and large capitalization companies. They believe that sector specialization is critical to the early identification of investment ideas.

Recent Transactions
Details Hidden

Jazz Pharmaceuticals Plc purchases Cavion, Inc. from Lilly Ventures Management Co. LLC, Novartis Venture Fund, Center for Innovative Technology, Enso Ventures Ltd.

Details Hidden

Jazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Details Hidden

Jazz Pharmaceuticals Plc purchases Jazz Pharmaceuticals II SASU from Turenne Capital Partenaires SA, Octalfa SAS

Transaction Advisors
Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Gentium Srl

Underwriter

Advised onJazz Pharmaceuticals Plc issued USD Ordinary Shares

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Gentium Srl

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Partner In Charge-Palo Alto at Cooley LLP

Legal Advisor

Partner, San Diego at Cooley LLP

Legal Advisor

Partner at Cooley LLP

Clients

Cigna Corp. is a global health service company, which is dedicated to improving the health, well-being and peace of mind. Its products and services include an integrated suite of health services such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products including group life, accident and disability insurance.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Key Stats and Financials As of 2019
Market Capitalization
$8.99B
Total Enterprise Value
$9.28B
Earnings Per Share
$9.09
Revenue
$2.16B
Net Profit
$523M
EBITDA
$1.01B
EBITDAMargin
46.84%
Total Debt
$1.77B
Total Equity
$3.11B
Enterprise Value / Sales
4.3x
Enterprise Value EBITDAOperating
9.01x
TEVNet Income
17.74x
Debt TEV
0.19x
Three Year Compounded Annual Growth Rate Of Revenue
13.26%
Investments
Details Hidden

Onera Health, Inc. enagges in the provision of sleep diagnostic solutions and services. It develops sleeping medicines. The company was founded by Raphael Michel, Ruben de Francisco, Hartmut Schneider, Soukaina Adnane, and Pieter Ermers and is headquartered in Palo Alto, CA.

Details Hidden

Arrivo Management LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC.

Investors
Details Hidden

Founder at Foresite Capital Management LLC

Suppliers
Concert Pharmaceuticals, Inc. Medical Support Services | Lexington, MA

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.

Siegfried Holding AG Pharmaceuticals | Zofingen, Switzerland

Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. It also provides development and production services for finished dosage forms including sterile filling. The company was founded by Samuel Benoni Siegfried in 1873 and is headquartered in Zofingen, Switzerland.

Pfenex, Inc. Pharmaceuticals | San Diego, CA

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Competitors
Avadel Pharmaceuticals Plc Pharmaceuticals - Dublin, Ireland

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Axsome Therapeutics, Inc. Pharmaceuticals - New York, NY

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 which are developing for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jazz Pharmaceuticals Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jazz Pharmaceuticals Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and Jazz Pharmaceuticals Plc.